Role of Junctional Adhesion Molecule-C in Arthritis
Author Information
Author(s): Gaby Palmer, Nathalie Busso, Michel Aurrand-Lions, Dominique Talabot-Ayer, Véronique Chobaz-Péclat, Claudia Zimmerli, Philippe Hammel, Beat A. Imhof, Cem Gabay
Primary Institution: University Hospital, Geneva, Switzerland
Hypothesis
What is the role of junctional adhesion molecule-C (JAM-C) in the pathogenesis of arthritis?
Conclusion
JAM-C is highly expressed by synovial fibroblasts in rheumatoid arthritis, and treatment with an anti-JAM-C antibody significantly reduced the severity of antigen-induced arthritis and delayed the onset of serum transfer-induced arthritis.
Supporting Evidence
- JAM-C expression was significantly higher in rheumatoid arthritis compared to osteoarthritis samples.
- Treatment with anti-JAM-C antibody decreased the severity of antigen-induced arthritis in mice.
- Neutrophil infiltration into inflamed joints was selectively reduced in anti-JAM-C-treated mice.
Takeaway
JAM-C is a protein that helps cells stick together, and blocking it can make arthritis less severe in mice.
Methodology
The study involved examining JAM-C expression in human and mouse synovial tissues and testing the effects of a monoclonal anti-JAM-C antibody in mouse models of arthritis.
Participant Demographics
Human synovial tissue samples from patients with rheumatoid arthritis and osteoarthritis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website